NHS backs epilepsy app
Epilepsy Society welcomes the inclusion of an epilepsy self-management tool, EpSMon, as one of only eight innovations to join the NHS Innovation Accelerator (NIA) programme. Each innovation focuses on providing solutions to key challenges facing the NHS and it is hoped this tool will lead to a reduction in the number of epilepsy-related deaths and a decrease in A&E appointments for epilepsy.
EpSMon is an app which enables patients to monitor their well-being and know when to seek medical support. It is based on evidence from the SUDEP (sudden unexpected death in epilepsy) and Seizure Safety Check List, a facility that enables clinicians to monitor changes in risk factors in their patients. The evidence comes from a study that was funded by Kt’s Fund, a charity set up in memory of Katie Hallet, a young nurse who died suddenly aged 20 from epilepsy.
The app was launched last year and is available for free across mobile technology platforms. It has already won a tranche of industry awards. Dr. Craig Newman, research fellow at Plymouth University who developed the app, is shortlisted for the prestigious Health Service Journal Rising Star award. He said ‘This is great recognition for a self-monitoring tool which is already making a difference to people’s lives. This is a true partnership project combining research, clinical expertise and condition knowledge.’
EpSMon has been developed by a partnership including charity SUDEP Action, Cornwall Partnership NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and Plymouth University.
The NHS Innovation Accelerator (NIA) is in its second year. It supports some of the best national and international innovations to help improve health outcomes and give patients access to the latest products, services and technology at lower cost. Last year 17 innovations were supported by the NHS and rolled out across more than 380 NHS organisations.
Share this article: